Forum Discussion
Bisphosphonates to reduce bone mets
I’d like to share something that I’ve learned from my oncologist. Bisphosphonates are used to reduce bone density loss in people who are being treated with AI for estrogen receptive breast cancer. O...
'Lancet Oncology' (May 2019) on denosumab's (Prolia) benefit for reducing bone fracture risk but little evidence for survival benefit: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30146-9/fulltext